- 12-Week # shares sold: 23,693
- 24-Week # shares sold: 23,693
- 4-Week # shares sold: 172,681
- 12-Week # shares sold: 175,606
- 24-Week # shares sold: 175,606
- 4-Week # shares sold: 15,318
- 12-Week # shares sold: 15,318
- 24-Week # shares sold: 15,318
Akorn shares could fall as much as 34% Monday after Germany's Fresenius Medical ditched its planned $5 billion takeover amid allegations of data misconduct at the Lake Forest, Ill.-based generic drugmaker.
Stock futures are lower as benchmark 10-year Treasury notes inch closer to 3%; Google parent Alphabet, T-Mobile US and Hasbro report earnings; Akorn plunges after Germany's Fresenius drops its planned $5 billion takeover of the generic drugmaker.
The mid-term elections are coming, and investors would be wise to brace for the return of even more volatility in the markets,
The U.S. earnings seasons accelerates this week with 180 S&P 500 companies reporting, including big tech names such as Google, Facebook, Amazon and Microsoft.
Global stocks pulled back from recent gains Monday as investors eyed developments in the bond market which could take benchmark 10-year U.S. Treasury yields past 3% for the first time since 2014.